(Q38007899)

26 August 2017

title

Prediabetic neuropathy: does it exist? (English)

1 reference

26 August 2017

Nikolaos Papanas

1

1 reference

26 August 2017

Dan Ziegler

series ordinal

2

1 reference

26 August 2017

publication date

1 August 2012

1 reference

26 August 2017

published in

Current diabetes report

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

376-383

1 reference

Diabetic neuropathies: a statement by the American Diabetes Association

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Diabetic cardiovascular autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Residual microvascular risk in diabetes: unmet needs and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Current concepts in the management of diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Painful diabetic neuropathy: advantage of novel drugs over old drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

The diabetic foot: grand overview, epidemiology and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

The diabetic foot: established and emerging treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Neuropathy: the crystal ball for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Somatic neuropathy is an independent predictor of all- and diabetes-related mortality in type 2 diabetic patients: a population-based 5-year follow-up study (KCIS No. 29).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Neuropathy in prediabetes: does the clock start ticking early?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Impaired glucose tolerance and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Painful sensory polyneuropathy associated with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

The spectrum of neuropathy in diabetes and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Lifestyle intervention for pre-diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Mechanism of diabetic neuropathy: Where are we now and where to go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Assessment of neuropathic pain in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Early diabetic neuropathy: triggers and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Neurons undergo apoptosis in animal and cell culture models of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Diabetes regulates mitochondrial biogenesis and fission in mouse neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

What does postprandial hyperglycaemia mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Prevalence of somatic small fiber neuropathy in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Idiopathic neuropathy patients are at high risk for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Small fiber neuropathy is associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Hyperlipidemia: a new therapeutic target for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Diabetic neuropathy in Mauritius: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Impaired glycemia and diabetic polyneuropathy: the OC IG Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Epidemiological evidence of altered cardiac autonomic function in overweight but not underweight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: evidence for distinct pathways: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0278-3

Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey

21 January 2018

1 reference

12 December 2020

Peripheral neuropathy with impaired glucose tolerance: a sweet smell of success?

1 reference

12 December 2020

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

12 December 2020

A rational diagnostic approach to peripheral neuropathy.

1 reference

12 December 2020

Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance.

1 reference

12 December 2020

Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study

1 reference

12 December 2020

Impaired glucose tolerance is associated with postganglionic sudomotor impairment

1 reference

12 December 2020

Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves

1 reference

12 December 2020

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

1 reference

12 December 2020

Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis

1 reference

12 December 2020

Diabetic neuropathy: new strategies for treatment

1 reference

12 December 2020

Utility of skin biopsy to evaluate peripheral neuropathy

1 reference

12 December 2020

Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab

1 reference

12 December 2020

Diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

10.1007/S11892-012-0278-3

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1032782412

0 references

1 reference